logo

For the Inventor, By the Inventor

Tokushima, Japan

Hiroyuki Ichikawa

This inventor holds 11 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Ichikawa. Retrieved from https://idiyas.com/inventor/hiroyuki-ichikawa-65tuv67y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal11 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents

Years Active: 1995-1999

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5925640 - Apoptosis regulating composition (1999-07-20),
2. 5916890 - Apoptosis regulating composition (1999-06-29),
3. 5872120 - Apoptosis regulating composition (1999-02-16),
4. 5837230 - Methods of treating allergies with M-CSF (1998-11-17),
5. 5798358 - Apoptosis regulating composition (1998-08-25),
6. 5750529 - Apoptosis regulating compostion (1998-05-12),
7. 5691341 - Apoptosis regulating composition (1997-11-25),
8. 5672603 - Apoptosis regulating composition (1997-09-30),
9. 5658912 - Apoptosis regulating composition (1997-08-19),
10. 5543412 - Hepatitis treatment with carbostyril compounds (1996-08-06),
11. 5464833 - Apoptosis regulating composition (1995-11-07),

Title: Hiroyuki Ichikawa: Innovator in Apoptosis Regulation

Introduction

Hiroyuki Ichikawa is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of apoptosis regulation, holding a total of 11 patents. His work focuses on developing compositions that can effectively regulate apoptosis, which is crucial for various biological processes.

Latest Patents

Ichikawa's latest patents include an apoptosis regulating composition. The objective of this invention is to provide a composition that comprises, as an active ingredient, at least one carbostyril derivative of a specific general formula and its salts. This innovative approach aims to enhance the understanding and application of apoptosis regulation in medical science.

Career Highlights

Hiroyuki Ichikawa is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development in his field. His expertise and innovative mindset have led to the creation of valuable patents that contribute to the pharmaceutical industry.

Collaborations

Ichikawa has collaborated with notable colleagues, including Satoru Nakai and Koutoku Aihara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hiroyuki Ichikawa's work in apoptosis regulation exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of medical research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…